Rocket Pharmaceuticals, Inc. Property, Plant and Equipment
Rocket Pharmaceuticals, Inc. (RCKT) had Property, Plant and Equipment of $25.10 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-10
- 2026-06-30: Property, Plant and Equipment, Net $25.10M.
- 2026-03-31: Property, Plant and Equipment, Net $26.66M.
- 2025-12-31: Property, Plant and Equipment, Net $28.17M.
- 2025-09-30: Property, Plant and Equipment, Net $29.77M.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $25.10M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $26.66M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $28.17M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $29.77M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $32.52M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $34.56M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $36.79M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $38.51M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $39.55M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $39.34M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $39.17M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $36.53M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $32.99M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $30.59M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $29.01M 10-K · filed 2024-02-27 | |
| 2022-09-30 | $25.61M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $24.85M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $24.35M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $22.30M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $22.09M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $20.99M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $19.83M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $19.21M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $15.80M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $14.31M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $11.14M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $29.52M 10-K · filed 2021-03-01 | $29.30M 10-K · filed 2020-03-06 |
| 2019-09-30 | $19.27M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $9.84M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $7.08M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $2.03M 10-K · filed 2020-03-06 | |
| 2018-09-30 | $1.25M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $976.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.15M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $985.00K 10-K · filed 2019-03-08 | $563.00K 10-K · filed 2018-03-07 |
| 2017-09-30 | $615.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $1.08M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $1.12M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.13M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $1.04M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $976.00K 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $790.00K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $812.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $756.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $29.00K 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |